Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Identifieur interne : 009409 ( Ncbi/Merge ); précédent : 009408; suivant : 009410Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Auteurs : David I. Kaufman [États-Unis] ; Chirag Shah [États-Unis] ; Frank A. Vicini [États-Unis] ; Marisa Rizzi [États-Unis]Source :
- Breast cancer research and treatment [ 1573-7217 ] ; 2017.
Abstract
This analysis was performed to assess the impact of early intervention following prospective surveillance using bioimpedance spectroscopy (BIS) to detect and manage breast cancer-related lymphedema (BCRL).
DOI: 10.1007/s10549-017-4451-x
PubMed: 28831632
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000036
- to stream PubMed, to step Curation: 000036
- to stream PubMed, to step Checkpoint: 000036
Links to Exploration step
pubmed:28831632Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.</title><author><name sortKey="Kaufman, David I" sort="Kaufman, David I" uniqKey="Kaufman D" first="David I" last="Kaufman">David I. Kaufman</name><affiliation wicri:level="2"><nlm:affiliation>Breast Care Specialists, Bethpage, NY, USA. dkat727@aol.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Breast Care Specialists, Bethpage, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Shah, Chirag" sort="Shah, Chirag" uniqKey="Shah C" first="Chirag" last="Shah">Chirag Shah</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Vicini, Frank A" sort="Vicini, Frank A" uniqKey="Vicini F" first="Frank A" last="Vicini">Frank A. Vicini</name><affiliation wicri:level="2"><nlm:affiliation>Michigan Healthcare Professionals, 21st Century Oncology, Farmington Hills, MI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Michigan Healthcare Professionals, 21st Century Oncology, Farmington Hills, MI</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Rizzi, Marisa" sort="Rizzi, Marisa" uniqKey="Rizzi M" first="Marisa" last="Rizzi">Marisa Rizzi</name><affiliation wicri:level="2"><nlm:affiliation>Breast Care Specialists, Bethpage, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Breast Care Specialists, Bethpage, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28831632</idno><idno type="pmid">28831632</idno><idno type="doi">10.1007/s10549-017-4451-x</idno><idno type="wicri:Area/PubMed/Corpus">000036</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000036</idno><idno type="wicri:Area/PubMed/Curation">000036</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000036</idno><idno type="wicri:Area/PubMed/Checkpoint">000036</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000036</idno><idno type="wicri:Area/Ncbi/Merge">009409</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.</title><author><name sortKey="Kaufman, David I" sort="Kaufman, David I" uniqKey="Kaufman D" first="David I" last="Kaufman">David I. Kaufman</name><affiliation wicri:level="2"><nlm:affiliation>Breast Care Specialists, Bethpage, NY, USA. dkat727@aol.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Breast Care Specialists, Bethpage, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Shah, Chirag" sort="Shah, Chirag" uniqKey="Shah C" first="Chirag" last="Shah">Chirag Shah</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Vicini, Frank A" sort="Vicini, Frank A" uniqKey="Vicini F" first="Frank A" last="Vicini">Frank A. Vicini</name><affiliation wicri:level="2"><nlm:affiliation>Michigan Healthcare Professionals, 21st Century Oncology, Farmington Hills, MI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Michigan Healthcare Professionals, 21st Century Oncology, Farmington Hills, MI</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Rizzi, Marisa" sort="Rizzi, Marisa" uniqKey="Rizzi M" first="Marisa" last="Rizzi">Marisa Rizzi</name><affiliation wicri:level="2"><nlm:affiliation>Breast Care Specialists, Bethpage, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Breast Care Specialists, Bethpage, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><series><title level="j">Breast cancer research and treatment</title><idno type="eISSN">1573-7217</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This analysis was performed to assess the impact of early intervention following prospective surveillance using bioimpedance spectroscopy (BIS) to detect and manage breast cancer-related lymphedema (BCRL).</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">28831632</PMID><DateCreated><Year>2017</Year><Month>08</Month><Day>23</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7217</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2017</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>Breast cancer research and treatment</Title><ISOAbbreviation>Breast Cancer Res. Treat.</ISOAbbreviation></Journal><ArticleTitle>Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10549-017-4451-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This analysis was performed to assess the impact of early intervention following prospective surveillance using bioimpedance spectroscopy (BIS) to detect and manage breast cancer-related lymphedema (BCRL).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From 8/2010 to 12/2016, 206 consecutive patients were evaluated with BIS. The protocol included pre-operative assessment with L-Dex as well as post-operative assessments at regular intervals. Patients with L-Dex scores >10 from baseline were considered to have subclinical BCRL and were treated with over-the-counter (OTC) compression sleeve for 4 weeks. High-risk patients were defined as undergoing axillary lymph node dissection (ALND), receiving regional nodal irradiation (RNI), or taxane chemotherapy. Chronic BCRL was defined as the need for complex decongestive physiotherapy (CDP).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median follow-up was 25.9 months. Overall, 17% of patients had one high-risk feature, 8% two, and 7% had three. 9.8% of patients were diagnosed with subclinical BCRL with highest rates seen following ALND (23 vs. 7%, p = 0.01). Development of subclinical BCRL was associated with ALND and receipt of RNI. At last follow-up, no patients (0%) developed chronic, clinically detectable, BCRL. Subset analysis was performed of the 30 patients undergoing ALND. Median number of nodes removed was 18 and median number of positive nodes was 2. 77% received taxane chemotherapy, 62% axillary RT, and 48% had elevated BMI. Overall, 86% of patients had at least one additional high-risk feature, 70% at least two, and 23% had all three. Seven patients (23%) had abnormally elevated L-Dex scores at some point during follow-up. To date, none has required CDP.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of this study support prospective surveillance utilizing BIS initiated pre-operatively with subsequent post-operative follow-up measurements for the detection of subclinical BCRL. Intervention triggered by subclinical BCRL detection with an elevated L-Dex score was associated with no cases progressing to chronic, clinically detectable BCRL even in very high-risk patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>David I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Breast Care Specialists, Bethpage, NY, USA. dkat727@aol.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Chirag</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicini</LastName><ForeName>Frank A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Michigan Healthcare Professionals, 21st Century Oncology, Farmington Hills, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Marisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Breast Care Specialists, Bethpage, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Breast Cancer Res Treat</MedlineTA><NlmUniqueID>8111104</NlmUniqueID><ISSNLinking>0167-6806</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bioimpedance spectroscopy</Keyword><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">L-Dex</Keyword><Keyword MajorTopicYN="N">Lymphedema</Keyword><Keyword MajorTopicYN="N">Survivorship</Keyword><Keyword MajorTopicYN="N">Toxicity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28831632</ArticleId><ArticleId IdType="doi">10.1007/s10549-017-4451-x</ArticleId><ArticleId IdType="pii">10.1007/s10549-017-4451-x</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Michigan</li><li>Ohio</li><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Kaufman, David I" sort="Kaufman, David I" uniqKey="Kaufman D" first="David I" last="Kaufman">David I. Kaufman</name></region><name sortKey="Rizzi, Marisa" sort="Rizzi, Marisa" uniqKey="Rizzi M" first="Marisa" last="Rizzi">Marisa Rizzi</name><name sortKey="Shah, Chirag" sort="Shah, Chirag" uniqKey="Shah C" first="Chirag" last="Shah">Chirag Shah</name><name sortKey="Vicini, Frank A" sort="Vicini, Frank A" uniqKey="Vicini F" first="Frank A" last="Vicini">Frank A. Vicini</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009409 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 009409 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28831632
|texte= Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28831632" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |